Second, and more fundamentally, compounding eligibility is not drug approval
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
#atai #beckley #psychedelic #psychiatry #TRD #depression #BPL003 #biotech To view or add a comment, sign in : Learn how to use the supplement lithium orotate safely and effectively in clinical practice
If you want to use an article on your site please direct to and cite the original article page
However, the amount of B12 absorption it is very difficult to measure
